Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment
Jie Yang, Bin Li, Qing‐Yu He
Cell Death and Disease (2018) Vol. 9, Iss. 6
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics
Debasna Pritimanjari Panigrahi, Prakash Priyadarshi Praharaj, Chandra Sekhar Bhol, et al.
Seminars in Cancer Biology (2019) Vol. 66, pp. 45-58
Closed Access | Times Cited: 252
PHB2 promotes colorectal cancer cell proliferation and tumorigenesis through NDUFS1-mediated oxidative phosphorylation
Lin Ren, Meng Li, Jing Gao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40
Integrating functional proteomics and next generation sequencing reveals potential therapeutic targets for Taiwanese breast cancer
Wei‐Chi Ku, Chih-Yi Liu, Chi‐Jung Huang, et al.
Clinical Proteomics (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Emerging roles of prohibitins in cancer: an update
Yunliang Gao, Yuanyuan Tang
Cancer Gene Therapy (2025)
Closed Access | Times Cited: 1
Akt Isoforms: A Family Affair in Breast Cancer
Alakananda Basu, Christoffer Briggs Lambring
Cancers (2021) Vol. 13, Iss. 14, pp. 3445-3445
Open Access | Times Cited: 47
Essential Protein PHB2 and Its Regulatory Mechanisms in Cancer
Amanda Qi, Lillie Lamont, Evelyn Liu, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1211-1211
Open Access | Times Cited: 19
Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN3-Derived Lipid for Synergistic Lung Cancer Therapy
Yaxuan Liang, Xueyi Sun, De-Zhong Xu, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 5, pp. 3202-3214
Closed Access | Times Cited: 7
PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer
Liang Xu, Wanying Xiang, Jiezhen Yang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases
Dong Wang, Redouane Tabti, Sabria Elderwish, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 18, pp. 3525-3546
Open Access | Times Cited: 49
Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines
Pinar Uysal‐Onganer, Amy MacLatchy, Mahmoud Rayan, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1495-1495
Open Access | Times Cited: 44
PHB2 promotes tumorigenesis via RACK1 in non-small cell lung cancer
Bin Wu, Ning Chang, Hangtian Xi, et al.
Theranostics (2021) Vol. 11, Iss. 7, pp. 3150-3166
Open Access | Times Cited: 39
Cell‐to‐cell contact‐mediated regulation of tumor behavior in the tumor microenvironment
Akira Sato, Nor Idayu A. Rahman, Akio Shimizu, et al.
Cancer Science (2021) Vol. 112, Iss. 10, pp. 4005-4012
Open Access | Times Cited: 33
Protein phosphatase 1 in tumorigenesis: is it worth a closer look?
Juliana Felgueiras, Cármen Jerónimo, Margarida Fardilha
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188433-188433
Closed Access | Times Cited: 33
Antitumor mechanism of cannabidiol hidden behind cancer hallmarks
Chaobiao Yan, Li Yu, Hanqing Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188905-188905
Closed Access | Times Cited: 13
A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3—PBX1 and β-catenin—ABCG2 signaling
Chia-Hsun Fang, Yi-Te Lin, Chi‐Ming Liang, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 29
Inner mitochondrial membrane protein Prohibitin 1 mediates Nix-induced, Parkin-independent mitophagy
Kibrom M. Alula, Yaritza Delgado‐Deida, Rosemary Callahan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Prohibitins in infection: potential therapeutic targets
Nuo Chen, Xiaolan Liu, L. Wang, et al.
Future Microbiology (2025), pp. 1-11
Closed Access
Prohibitin2 knockdown decreases glioma malignant phenotypes and radio-resistance by inhibiting mitophagy
Xuefei Xue, Huiling Tan, Xiaofan Jiang, et al.
International Journal of Radiation Biology (2025), pp. 1-12
Closed Access
Investigation of new autoantibodies in urothelial bladder cancer for biomarker discovery using immunoproteomics
Samira Tabaei, Mohammadrasul Zareinejad, Mohammad Reza Haghshenas, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Prognostic Impact of Phenotypic and Genetic Features of Pancreatic Malignancies
M. B. Potievskiy, Lidia A. Nekrasova, Ivan V. Korobov, et al.
Life (2025) Vol. 15, Iss. 4, pp. 635-635
Open Access
The E3 Ubiquitin Ligase ARIH1 Facilitates Colorectal Cancer Progression by Promoting Oxidative Phosphorylation via the Mitochondrial Translocation of K63‐Linked Ubiquitinated PHB1
Ying Tong, Zhenling Wang, Yong Wang, et al.
Advanced Science (2025)
Open Access
Prohibitin 1 in liver injury and cancer
Lucía Barbier‐Torres, Shelly C. Lu
Experimental Biology and Medicine (2020) Vol. 245, Iss. 5, pp. 385-394
Open Access | Times Cited: 26
The function of prohibitins in mitochondria and the clinical potentials
Linda Oyang, Jian Li, Xianjie Jiang, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme
Jinghua Wang, Xinqi Qiu, Jiayu Huang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis
Wei Fan, Duo‐Yao Cao, Bing Yang, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 3, pp. 443-453
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top